ATCC Announces Award from the NCI to Provide Biospecimen Processing Services and Assays for Cancer Research
NCI awarded ATCC a five-year contract with a ceiling value of $7.37 million to provide biospecimen processing services and assays for cancer research.
ATCC and Tissue Dynamics Announce Strategic Collaboration to Bring a Transformative Heart Organoid Model to Market
ATCC and Tissue Dynamics announced a partnership to develop workflow-friendly cardiac organoid-based kits for improved cardiac safety testing in drug development.
ATCC Announces New Award from BARDA to Provide Centralized Storage and Bioprocessing Services for Project NextGen
ATCC announced a 5-year, $87 million award from BARDA to support the development of next-generation medical countermeasures.
